Document is current
Any future updates will be listed below
-
Authors
Goetti, Patrick
Martinho, Tiago
Seurot, Antoine
Bothorel, Hugo
Lädermann, Alexandre https://orcid.org/0000-0002-2797-8936
-
Funding
Funding for this research was provided by:
FORE (2022-29)
University of Geneva
- License Information
-
More Information
Article History
Received: 9 July 2022
Accepted: 17 February 2023
First Online: 27 February 2023
Declarations
:
: The trial is currently ongoing. The protocol was approved by the ethical committee board (CCER 2019–02469) in April 2020 and by ClinicalTrials.gov (Identifier: NCT04479397) in July 2020. All patients agree to participate, and a written consent will be obtained from all participants.
: All data will be available on request at the following email address: alexandre.laedermann@gmail.com.
: Informed consent from was approved by the ethical committee board (CCER 2019–02469) in April 2020. No identifying images or other personal or clinical details of participants are presented here or will be presented in reports of the trial results. Informed consent materials are available from the corresponding author on request.
: AL is a paid consultant for Stryker, Medacta, and Arthrex. He receives royalties from Stryker. He is the founder of FORE, BeeMed, and Med4Cast. He owns stock options of Medacta, BeeMed, and FollowHealth. The other authors declare that they have no competing interests.
